Page 7 - 2020Taiwan Food and Drug Administration Annual Report

The mission of the Taiwan Food and Drug Administration (TFDA) advanced public health by
helping them to have safe and effective medicinal products, safe and healthy food. Under the vision of

“Being a reliable guardian on food and medicinal product safety” and “Creating a safe food and medicinal
consumer environment.” TFDA aims to regulate the safety and quality of food, drugs, medical devices, and
cosmetics that are daily used by the public, and promote every citizen’s health and the public welfare at
the same time. In order to document the important policies and implementation of TFDA, an annual report
that summarizes various important policies, plans, and achievements in the previous year is prepared every
year and published domestically and internationally for reference.
In 2019, TFDA continued to improve its work in various aspects and achieved excellent results. For

IRRG VDIHW\ PDQDJHPHQW LQ RUGHU WR WDFNOH WKH FXUUHQW UDSLG IRRG GHYHORSPHQWV VXFK DV GLYHUVL¿FDWLRQ
novelty, and digitalization, we adopted the full life-cycle management model of farm-to-table to ensure
the hygiene and safety of food in the food production chain. Moreover, TFDA stipulated the “Guidelines
of Hygiene Self-Management for Online Food Delivery Platform Business Operators” to strengthen hygiene
management. TFDA also intensified the implementation of the “Five-Point Food Safety Policy” and
continued to carry out food safety related work. In addition, TFDA has created a comprehensive
management system to ensure a “Safe and Healthy” food environment for consumers through the cross-
departmental coordination, multiple review, and risk management by implementation of big data.
The management of the drug life cycle must be in compliance with good operating practices,

furthermore, to effectively ensure the safety, efficacy, and quality of pharmaceutical products, TFDA
has put considerable effort into improving drug management regulations and its vital participation in
international events to enhance Taiwan’s participation in the management of pharmaceutical administration
internationally as well as create a regulatory environment that is in line with international standards.
In order to reinforce risk management, we continue to improve the drug registration and review
mechanism, pharmaceutical distribution and marketing regulations, digital management, quality and safety
management, and quality inspection technology, to achieve a win-win situation for consumers, business

operators, and the government.